|1.||Knight, John C: 1 article (03/2009)|
|2.||Thornhill, Andrew: 1 article (03/2009)|
|3.||Pettit, George R: 1 article (03/2009)|
|4.||Melody, Noeleen: 1 article (03/2009)|
03/27/2009 - "Compared to combretastatin A-2 (1), stilstatin 1 (2) has an additional vicinal hydroxy group on the B ring, the presence of which was detrimental to the cancer cell line potency; in vivo, however, compound 2 would be predicted to have greater anticancer activity resulting from the o-quinone mechanism of action analogous to that of combretastatin A-1 (4). "